ARLINGTON HEIGHTS, Ill., Sept. 20, 2016 -- Sonoco ThermoSafe, a unit of Sonoco (NYSE:SON) and a leading global provider of temperature-assurance packaging, has acquired the assets and operations of Laminar Medica in the United Kingdom and Czech Republic, from Clinimed (Holdings) Limited, a privately held specialty medical products company based in the U.K. Terms of the transaction were not disclosed.
Established in 1975 in London, Laminar Medica specializes in the design, test, manufacture and qualification of temperature-controlled packaging solutions, used by the pharmaceutical and biotech industries globally. The business provides solutions for products that need refrigerated, ambient and frozen temperature control for shipment ranging from 24-hours to 120-hours in duration.
Laminar’s insulated parcel and pallet shipping solutions are marketed globally under well-established brands, including ChillTherm®, FreezeTherm®, ClimiTherm®, MediPhase®, MediPorter®, MediSorb®, and newly launched ChillTech® and AmbiTech® product lines. More information about Laminar’s products and services is available at www.laminarmedica.com.
“By adding Laminar Medica, we are significantly expanding Sonoco ThermoSafe’s global presence and providing our customers local access to the widest range of insulated parcel and pallet solutions,” said Russell Grissett, general manager of Sonoco Thermosafe. “Laminar’s strong brands, manufacturing, design, testing and qualification capabilities in the United Kingdom and Europe complements ThermoSafe’s current footprint to provide our customers the level of trust, confidence and customer experience they have grown to expect from a global market leader in temperature-assurance solutions.”
Vicki Arthur, vice president of Sonoco Protective Solutions, which includes Sonoco Thermosafe, added, “As our customers in the pharmaceutical and biotech industry continue to expand internationally, we believe the addition of Laminar Medica demonstrates our commitment to be a global partner our customers can continue to collaborate with for their evolving temperature-assurance logistics needs.”
About Sonoco ThermoSafe
Sonoco ThermoSafe is a leading global provider of temperature-assurance packaging for the safe and efficient transport of pharmaceuticals, biologics, vaccines and other temperature-sensitive products. Sonoco ThermoSafe shipping solutions mitigate risk for our customers and ensure product efficacy throughout the extremes of a supply chain. With operations in North America, South America, Europe and Asia, Sonoco ThermoSafe has a vast product offering featuring industry-leading technology that encompasses refrigerated, frozen or controlled room-temperature applications. In addition, Sonoco ThermoSafe's ISC Labs® design and testing services deliver individualized and innovative packaging solutions along with qualification and validation services to meet all regulatory requirements. More information can be found at www.thermosafe.com.
About Sonoco
Founded in 1899, Sonoco is a global provider of a variety of consumer packaging, industrial products, protective packaging, and displays and packaging supply chain services. With annualized net sales of nearly $5 billion, the Company has 20,800 employees working in more than 300 operations in 34 countries, serving some of the world’s best known brands in some 85 nations. For more information on the Company, visit our website at www.sonoco.com.
Contact: Roger Schrum +843-339-6018 [email protected]


TSMC Japan's Second Fab to Produce 3nm Chips by 2028
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Bank of America's $72.5M Epstein Settlement: What You Need to Know
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations 



